PDB-LOCS

Programmable Droplet-based Lab on a Chip Systems

Coordinatore	more  Organization address address: ESKISEHIR YOLU 8 KM city: ANKARA postcode: TR-06800 contact info Titolo: Dr. Nome: Salim Cognome: Ciraci Email: send email Telefono: +90 312 2901213 Fax: +90 312 2664365
Nazionalità Coordinatore	Non specificata
Totale costo	100˙000 €
EC contributo	10˙000 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Anno di inizio	2012
Periodo (anno-mese-giorno)	2012-09-01   -   2016-08-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	Nome Ente NON disponibile  Organization address address: ESKISEHIR YOLU 8 KM city: ANKARA postcode: TR-06800 contact info Titolo: Dr. Nome: Salim Cognome: Ciraci Email: send email Telefono: +90 312 2901213 Fax: +90 312 2664365	TR (ANKARA)	coordinator	7˙190.86
2	KOC UNIVERSITY  Organization address address: RUMELI FENERI YOLU SARIYER city: ISTANBUL postcode: 34450 contact info Titolo: Ms. Nome: Sebnem Cognome: Dogan Email: send email Telefono: +90 212 338 1065 Fax: +90 212 338 1205	TR (ISTANBUL)	participant	92˙809.14

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Microfluidic systems offer great benefits in healthcare technologies such as reduction in reagent volume, high sensitivity, cost-efficiency and on-chip integration of multiple analyses. These benefits can be further enhanced using two phase flow microfluidic systems, i.e. microdroplet-based devices. The objective of this proposal is to develop programmable droplet-based lab-on-a-chip systems (PDB-LOCs) for tests/assays requiring high throughput and flexibility. The programmable platform will be a universal lab-on-a-chip device that can be used for multiple biochemical tests requiring different process steps. This will be achieved by routing microdroplets in a microfluidic network using electric field. At every junction at the fluidic network, droplets will be detected by capacitive sensing and will be routed using dielectrophoretic force. This will enable all-electronic detection and routing of microdroplets for programmability, compactness and ease-of-integration. Another goal of the project is to implement the sensing and routing of droplets using electrodes on printed circuit boards (PCBs) and achieve bonding of microfluidics chips on PCBs to have hybrid 'electro-fluidic' chips. This will facilitate the fabrication and will allow standardization of these lab-on-a-chip devices which will widen the application range of droplet-based systems by making them available to scientists in every field. The read-out and control electronics will be placed on the same PCB and a truly sample-in result-out system will be achieved. This project will narrow the gap between the proof-of-concept microfluidic technologies and commercial devices. Combining the strength of microfluidics with the robustness of electronics, next generation lab-on-a-chip devices will be enabled to boost European competitiveness in the healthcare market.'